SEC 13F Intelligence

Managers / Q4 2023 · view latest →

325 CAPITAL LLC

CIK 0001873893 · 757 THIRD AVENUE, 20TH FLOOR, NEW YORK, NY, 10017 · 212-376-5325

Reported Value
$202M
Q4 2023
Positions
13
Filings on Record
18
2019–present window
Filed
Feb 14, 2024
original filing

Summary

325 Capital LLC reported $202M in U.S.-listed holdings across 13 positions for Q4 2023.

Its largest position, BLBD, represents 15.6% of the portfolio.

Compared with Q3 2023, the fund opened 5 new positions and exited 0.

Portfolio Metrics

Turnover
+0.8%
vs prior filed quarter
Top-10 Concentration
+89.5%
share of reported value
Largest Position
+15.6%
Blue Bird

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $102MQ4 ’21Q1 ’22: $132MQ2 ’22: $108MQ3 ’22: $86MQ3 ’22Q4 ’22: $92MQ1 ’23: $114MQ2 ’23: $152MQ2 ’23Q3 ’23: $121MQ4 ’23: $202MQ1 ’24: $217MQ1 ’24Q2 ’24: $238MQ3 ’24: $236MQ4 ’24: $259MQ4 ’24Q1 ’25: $241MQ2 ’25: $253MQ3 ’25: $329MQ3 ’25Q4 ’25: $285MQ1 ’26: $274Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 85.9%ETP: 14.1%
  • Common Stock · 85.9% · $173M
  • ETP · 14.1% · $28M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SGOVISHARES TRNEW+284.1K284.1K+$28M$28M
IDCCINTERDIGITAL INCNEW+94.0K94.0K+$10M$10M
COHUCOHU INCNEW+216.8K216.8K+$8M$8M
LFCRLIFECORE BIOMEDICAL INCNEW+1.21M1.21M+$7M$7M
HTLDHEARTLAND EXPRESS INCNEW+523.4K523.4K+$7M$7M
DASEKE INCTRIMMED589.2K833.0K$548,493$7M
ATROASTRONICS CORPHELD53.8K1.64M+$2M$29M
BLBDBLUE BIRD CORPHELD19.8K1.16M+$6M$31M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2023

13 positions
#IssuerClass% PortfolioValueShares
1BLBDBLUE BIRD CORPhistory →COM15.55%$31M1.16M
2ATROASTRONICS CORPhistory →COM14.12%$29M1.64M
3SGOVISHARES TRhistory →0-3 MNTH TREASRY14.12%$28M284.1K
4ASTHAPOLLO MED HLDGS INChistory →COM NEW11.25%$23M592.8K
5BTMDBIOTE CORPhistory →CLASS A COM9.22%$19M3.77M
6MPAAMOTORCAR PTS AMER INChistory →COM6.50%$13M1.41M
7APEIAMERICAN PUB ED INChistory →COM6.14%$12M1.28M
8IDCCINTERDIGITAL INChistory →COM5.05%$10M94.0K
9COHUCOHU INChistory →COM3.80%$8M216.8K
10LFCRLIFECORE BIOMEDICAL INChistory →COM3.70%$7M1.21M
11HTLDHEARTLAND EXPRESS INChistory →COM3.70%$7M523.4K
12TACTTRANSACT TECHNOLOGIES INChistory →COM3.50%$7M1.01M
13DASEKE INCCOM3.34%$7M833.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$274M12May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$285M13Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$329M12Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$253M11Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$241M11May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$259M12Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M11Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$238M13Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$217M12May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$202M13Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$121M8Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$152M9Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$114M9May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$92M7Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$86M8Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$108M10Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$132M9May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$102M9Feb 14, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.